Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
International Journal of Cancer|November 16, 2020
Multiple lines of chemotherapy for patients with high-grade ovarian cancer: Predictors for response and effect on survivalRoy Kessous, Michel D Wissing, Ido Laskov, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 2023
Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancerNadav Michaan, Atalia Wenkert, Einat Even-Sapir, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 19, 2024
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitorsShira Peleg Hasson, Eliya Shachar, Miriam R Brezis, et al.BMC Medicine|September 11, 2015
Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitorsMaud Marques, Marie-Claude Beauchamp, Hubert Fleury, et al.Gynecologic Oncology|July 25, 2017
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancerLiron Kogan, Ido Laskov, Zainab Amajoud, et al.BMC Cancer|September 10, 2017
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitorsCharles-André Philip, Ido Laskov, Marie-Claude Beauchamp, et al.Gynecologic Oncology Reports|June 20, 2018
Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumorsLiron Kogan, David Octeau, Zainab Amajoud, et al.Journal of Personalized Medicine|September 28, 2021
Predictors of the CD24/CD11b Biomarker among Healthy SubjectsShiran Shapira, Gal Aiger, Amitay Ohayon, et al.Journal of Surgical Oncology|April 16, 2020
The impact of wait times on oncological outcome in high-risk patients with endometrial cancerCristina Mitric, Emad Matanes, Michel Wissing, et al.Gynecologic Oncology|February 4, 2018
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancerRoy Kessous, David Octeau, Kathleen Klein, et al.Pageof 7